Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Margin

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 11.259.406.17-0.4011.45

What is the latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE is 11.25 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202511.25
Mar20249.40
Mar20236.17
Mar2022-0.40
Mar202111.45

How is Core EBITDA Margin of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Margin % Change
Mar2025 11.25
19.68
Mar2024 9.4
52.35
Mar2023 6.17
Positive
Mar2022 -0.4
Negative
Mar2021 11.45 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Margin ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹7,341.0 Cr -3.5% -12.6% 36.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,329.0 Cr -0.2% -6.3% -8.8% Stock Analytics
DIVIS LABORATORIES ₹164,674.0 Cr 3.3% -3.4% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,891.0 Cr -0.7% 3.8% 26.3% Stock Analytics
CIPLA ₹107,292.0 Cr -3% -11.8% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹102,184.0 Cr 6% -3.5% -4.3% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-3.5%

-12.6%

36.4%

SENSEX

0.2%

-3.6%

8.6%


You may also like the below Video Courses